Here is a list of some of the most significant movers for Monday:


Stock gainers:

  • Stocks of Prometheus biosciences Inc. RXDX, +16.73% soared by nearly 70% following a Sunday deal between Merck & Co. Inc. MRK -0.26% and the biotech firm for $200 per share or $10.8 billion. Merck shares fell 0.4%.
  • Shares of the U.S. listed electric-vehicle manufacturer XPeng Inc. XPEV +15.22% rose over 13% after released a new platform which the company claims will reduce the R&D cycle for future models by 20%. Other Chinese EV makers such as Nio Inc. NIO +6.04%, and Li Auto Inc. also have shares listed in the U.S. The shares of Li Auto Inc., +6.39% and Nio Inc. NIO, +6.04% are also on the rise.
  • Charles Schwab Corp.’s (SCHW, +3.94%) stock rose 2% following the company’s earnings exceeding expectations in the most recent quarter. however fell short of revenue. M&T Bank Corp.’s MTB +7.78% was up more than 6% following the company ‘s earnings.
  • Amneal Pharmaceuticals Inc.’s (AMRX, +21.32%) stock surged 18% following the generics-and specialty pharmaceuticals company ‘s first-quarter guidance which exceeded consensus estimates.
  • JPMorgan upgraded HP Inc. HPQ to overweight, from neutral, while doing the opposite for Dell Technologies Inc.
  • Taiwan Semiconductor Manufacturing Ltd. Co. U.S. listed shares (TSM, +0.91%) were up 0.3% after receiving an upgrade from Susquehanna Financial Group.
  • Uber Technologies Inc., UBER, +1.99%, was up 1% in the Jefferies Top Picks after it replaced Airbnb Inc. ABNB +1.33%.


Stock decliners:

  • Alphabet Inc. shares GOOGL,-2.66% and GOOG–2.78% fell almost 3% during afternoon trading following a New York Times article that said Samsung Electronics Co.
  • State Street Inc. stock STT, +9.18% fell 9% on Monday after its first-quarter earnings were far below expectations. State Street Inc. said that it was facing revenue headwinds due to “significantly lower market levels”. Rival custodian Bank of New York Mellon Corp. BK -4.59% also fell and the last one was down 4%.
  • The share price of Marpai Inc. (MRAI,-43.32%) plummeted almost 38% following the announcement that the AI-health-tech company would be offering 7.4 million shares for $1 each, which is nearly half its $1.87 Friday closing price.
  • The shares of the vaccine maker Moderna Inc. MRNA, -8.36% fell 7% on afternoon trading, even though it released results from a trial of its cancer vaccination combined with Merck’s Keytruda. This combination showed a significant improvement in “recurrence free survival” for melanoma patient.
  • Infosys Ltd.’s (INFY) +0.07% U.S. listed shares fell 0.4% during afternoon trading. The digital-services firm’s India-based share 500209 – -9.40% dropped more than 9% following an downgrade by JPMorgan.
  • Roblox Corp.’s , RBLX -12.01% was down more than 11% following a drop in the number of daily active users.